# Bifido- and Lactobacilli in Symptomatic Adult COVID-19 Outpatients

> **NCT04907877** · NA · COMPLETED · sponsor: **Nordic Biotic Sp. z o.o.** · enrollment: 70 (actual)

## Conditions studied

- COVID-19 Respiratory Infection

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotic
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04907877
- **Lead sponsor:** Nordic Biotic Sp. z o.o.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-01
- **Primary completion:** 2022-12-01
- **Final completion:** 2023-03-01
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2023-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04907877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04907877, "Bifido- and Lactobacilli in Symptomatic Adult COVID-19 Outpatients". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04907877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*